Anoro Ellipta is a prescription medication used to treat chronic obstructive pulmonary disease (COPD). It is a combination of two active ingredients, umeclidinium and vilanterol, which work together to help improve lung function and reduce symptoms such as shortness of breath, coughing, and wheezing.

Umeclidinium is a long-acting muscarinic antagonist (LAMA) that helps to relax the muscles around the airways, making it easier to breathe. Vilanterol is a long-acting beta agonist (LABA) that helps to open up the airways by relaxing the muscles in the lungs.

Anoro Ellipta comes in the form of a dry powder inhaler that is easy to use and convenient for patients to take. It is typically taken once daily, at the same time each day, to help control symptoms and improve lung function.

It is important to follow the dosing instructions provided by your healthcare provider and to use Anoro Ellipta regularly as prescribed. It may take some time for you to notice the full benefits of this medication, so it is important to continue using it even if you do not immediately feel better.

As with any medication, Anoro Ellipta may cause side effects in some patients. These can include headache, sore throat, and cough. If you experience any severe or persistent side effects, it is important to contact your healthcare provider right away.

Overall, Anoro Ellipta is an effective and well-tolerated medication for the treatment of COPD. If you have been prescribed this medication, be sure to discuss any questions or concerns with your healthcare provider to ensure that it is the right choice for you.